We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Panacea Biotec Ltd on Wednesday said it has commenced production at its new formulation plant in Himachal Pradesh set up with an investment of around Rs 45 crore.
German drugmaker Schering AG's net profit rose by 21 percent in the first quarter, driven by sales of its multiple sclerosis treatment and its oral contraceptive, the company said Wednesday in a release of preliminary figures.
The Swiss pharmaceutical giant Roche says it has finished building a stockpile of three million courses of the antiviral drug Tamiflu for the World Health Organisation.
Adding Daiichi Sankyo's WelChol (colesevelam hydrochloride) to stable statin therapy - such as Zocor (simvastatin), Lipitor (atorvastatin calcium) or Pravachol (pravastatin sodium) -- further reduced mean LDL-C, or "bad" cholesterol, and median high-sensitivity C-reactive protein (hs-CRP) levels, according to research published in the American Journal of Cardiology.
Germany's Boehringer Ingelheim has reported that the European Commission (EC) has approved its Sifrol/Mirapexin (pramipexole) for the treatment of moderate-to-severe restless legs syndrome (RLS) in the EU.
Japan's Chugai Pharmaceutical has filed a new drug application (NDA) for erlotinib for advanced or recurrent non-small cell lung cancer (NSCLC) with the Japanese Ministry of Health, Labor and Welfare, the company reported.
India's bio-pharmaceutical companies, backed by a strong IT base and easy access to manpower, are busy positioning themselves to play a bigger role in the evolving global bio-generics market.
Lack of life-saving medicines, most of which are imported from India and third countries, has hit Nepal's hospitals and medical stores due to a continuing strike which has entered the 13th day on Tuesday.
Jubilant Organosys Ltd on Tuesday announced an increase of 31.7 per cent in net profit at Rs 47.4 crore for the fourth quarter 2005-06 as compared to Rs 36 crore for the same period in 2004-05.